Empreendimentos Pague Menos S.A. (PGMN3.SA)
BRL 2.98
(-4.49%)
BRL 2.98
(-4.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.32 Billion BRL | 14.89% |
| 2022 | 5.5 Billion BRL | 22.86% |
| 2021 | 4.48 Billion BRL | 17.58% |
| 2020 | 3.81 Billion BRL | 0.78% |
| 2019 | 3.78 Billion BRL | 61.29% |
| 2018 | 2.34 Billion BRL | 18.81% |
| 2017 | 1.97 Billion BRL | 4.1% |
| 2016 | 1.89 Billion BRL | -11.34% |
| 2015 | 2.13 Billion BRL | 45.06% |
| 2014 | 1.47 Billion BRL | 5.06% |
| 2013 | 1.4 Billion BRL | 44.43% |
| 2012 | 971.74 Million BRL | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.15 Billion BRL | -2.68% |
| 2024 Q2 | 5.93 Billion BRL | -3.57% |
| 2023 Q1 | 6.15 Billion BRL | 11.71% |
| 2023 Q4 | 6.32 Billion BRL | 3.08% |
| 2023 FY | 6.32 Billion BRL | 14.89% |
| 2023 Q3 | 6.13 Billion BRL | 13.31% |
| 2023 Q2 | 5.41 Billion BRL | -11.95% |
| 2022 Q4 | 5.5 Billion BRL | -4.88% |
| 2022 Q2 | 4.26 Billion BRL | -2.14% |
| 2022 Q1 | 4.36 Billion BRL | -2.67% |
| 2022 FY | 5.5 Billion BRL | 22.86% |
| 2022 Q3 | 5.79 Billion BRL | 35.62% |
| 2021 Q3 | 3.89 Billion BRL | 6.65% |
| 2021 FY | 4.48 Billion BRL | 17.58% |
| 2021 Q1 | 3.77 Billion BRL | -0.97% |
| 2021 Q2 | 3.65 Billion BRL | -3.26% |
| 2021 Q4 | 4.48 Billion BRL | 15.08% |
| 2020 Q3 | 3.84 Billion BRL | 1.76% |
| 2020 FY | 3.81 Billion BRL | 0.78% |
| 2020 Q1 | 3.8 Billion BRL | 0.56% |
| 2020 Q2 | 3.77 Billion BRL | -0.79% |
| 2020 Q4 | 3.81 Billion BRL | -0.72% |
| 2019 Q3 | 3.65 Billion BRL | -0.55% |
| 2019 FY | 3.78 Billion BRL | 61.29% |
| 2019 Q4 | 3.78 Billion BRL | 3.61% |
| 2019 Q2 | 3.67 Billion BRL | -2.82% |
| 2019 Q1 | 3.77 Billion BRL | 61.09% |
| 2018 Q1 | 2.1 Billion BRL | 6.42% |
| 2018 FY | 2.34 Billion BRL | 18.81% |
| 2018 Q4 | 2.34 Billion BRL | 1.82% |
| 2018 Q2 | 2.33 Billion BRL | 11.06% |
| 2018 Q3 | 2.3 Billion BRL | -1.27% |
| 2017 Q3 | 2.1 Billion BRL | 20.71% |
| 2017 FY | 1.97 Billion BRL | 4.1% |
| 2017 Q1 | 1.94 Billion BRL | 2.5% |
| 2017 Q2 | 1.74 Billion BRL | -10.34% |
| 2017 Q4 | 1.97 Billion BRL | -6.16% |
| 2016 FY | 1.89 Billion BRL | -11.34% |
| 2016 Q3 | 1.76 Billion BRL | 0.0% |
| 2016 Q4 | 1.89 Billion BRL | 7.67% |
| 2016 Q2 | 1.76 Billion BRL | -15.98% |
| 2016 Q1 | 2.09 Billion BRL | -1.99% |
| 2015 FY | 2.13 Billion BRL | 45.06% |
| 2015 Q1 | 1.42 Billion BRL | -3.25% |
| 2015 Q4 | 2.13 Billion BRL | 16.11% |
| 2015 Q3 | 1.84 Billion BRL | 12.52% |
| 2015 Q2 | 1.63 Billion BRL | 14.76% |
| 2014 Q1 | 1.12 Billion BRL | -5.71% |
| 2014 FY | 1.47 Billion BRL | 5.06% |
| 2014 Q2 | 1.25 Billion BRL | 11.88% |
| 2014 Q3 | 1.19 Billion BRL | -5.07% |
| 2014 Q4 | 1.47 Billion BRL | 23.57% |
| 2013 Q2 | 1.02 Billion BRL | 10.4% |
| 2013 FY | 1.4 Billion BRL | 44.43% |
| 2013 Q1 | 929.19 Million BRL | 0.0% |
| 2013 Q4 | 1.19 Billion BRL | 21.31% |
| 2013 Q3 | 982.34 Million BRL | -4.24% |
| 2012 FY | 971.74 Million BRL | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Raia Drogasil S.A. | 14.06 Billion BRL | 55.012% |